FGFR1 rearrangement
|
Head and Neck Cancer
|
FGFR1 rearrangement
|
Head and Neck Cancer
|
TAS 120 Sensitive: C3 – Early Trials
|
TAS 120 Sensitive: C3 – Early Trials
|
FGFR1 rearrangement
|
CNS Tumor
|
FGFR1 rearrangement
|
CNS Tumor
|
TAS 120 Sensitive: C3 – Early Trials
|
TAS 120 Sensitive: C3 – Early Trials
|
FGFR1 rearrangement
|
MDS
|
FGFR1 rearrangement
|
MDS
|
pemigatinib Sensitive: C3 – Early Trials
|
pemigatinib Sensitive: C3 – Early Trials
|